Estadístiques de Expert consensus on the management of adverse events of Lorlatinib in the treatment of ALK+ advanced non-small cell lung cancer
Visites totals
| views | |
|---|---|
| Expert consensus on the management of adverse events of Lorlatinib in the treatment of ALK+ advanced non-small cell lung cancer | 5 |
Visites totals per mes
| views | |
|---|---|
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 3 |
| May 2025 | 1 |
| June 2025 | 1 |
Visites al fitxer
| views | |
|---|---|
| Arriola_cdi_expe.pdf | 47 |